Chester County News and Community Website
WILMINGTON, DE — AstraZeneca has announced positive high-level results from its Phase III POTOMAC trial assessing the efficacy of IMFINZI® (durvalumab) combined with standard-of-care Bacillus Calmette-Guérin (BCG) induction and maintenance …
AstraZeneca’s IMFINZI® Demonstrates Promising Results in POTOMAC Phase III Trial for High-Risk NMIBC Read More
WILMINGTON, DE — Synnovation Therapeutics has announced the appointment of Rafael G. Amado, M.D., as a member of its Board of Directors, underscoring the company’s commitment to advancing scientific innovation …
Synnovation Therapeutics Welcomes Rafael G. Amado, M.D., to Board of Directors Read More
WILMINGTON, DE — Incyte (Nasdaq: INCY) announced it granted restricted stock unit awards (RSUs) totaling 33,413 shares of common stock and stock options to purchase 8,951 shares to 60 new …
Incyte Announces New Employee Stock Awards Under 2024 Inducement Plan Read More
WILMINGTON, DE — The Chemours Company (NYSE: CC) has entered a strategic agreement with Navin Fluorine International Limited (NSE: NAVINFLUOR) to manufacture Opteon™ two-phase immersion cooling fluid. This collaboration forms …
Chemours Partners with Navin Fluorine to Revolutionize Data Center Cooling Read More
WILMINGTON, DE — Global Indemnity Group, LLC (NYSE: GBLI) announced a net loss of $4.1 million, or $0.30 per share, for the first quarter of 2025, primarily driven by losses …
Global Indemnity Group Reports Q1 2025 Results, Details Wildfire Impact Read More WILMINGTON, DE — Positive results from the DESTINY-Breast11 Phase III trial revealed that ENHERTU® (fam-trastuzumab deruxtecan-nxki), when followed by paclitaxel, trastuzumab, and pertuzumab (THP), significantly improved pathologic complete response (pCR) …
ENHERTU Shows Promise in Early-Stage HER2-Positive Breast Cancer Read More WILMINGTON, DE — The Chemours Company (NYSE: CC) has released its financial results for the first quarter of 2025. The company reported net sales of $1.4 billion, consistent with the …
Chemours Reports Q1 2025 Financial Results, Highlights Strategic Initiatives Read More
WILMINGTON, DE — Phreesia, Inc. (NYSE: PHR) announced it will release its fiscal first quarter 2026 financial results before market opens on Wednesday, May 28, 2025. Previously, the results were …
Phreesia Updates Q1 2026 Earnings Release Schedule and Conference Call Details Read More
WILMINGTON, DE — Acorn Energy, Inc. (OTCQB: ACFN) posted strong financial results for the first quarter of 2025, showcasing significant revenue growth driven by its major contract with a leading …
Acorn Energy Reports Q1 2025 Growth and Nasdaq Uplisting Plans Read More
WILMINGTON, DE — Enovis™ Corporation (NYSE: ENOV) reported robust financial results for the first quarter ended April 4, 2025, showcasing steady growth across key segments and improved margins. The company …
Enovis Reports Strong Q1 2025 Results, Updates Financial Outlook Read More